AstraZeneca to buy Fusion Pharmaceuticals for up to $2.4 billion
-
AstraZeneca is buying Fusion Pharmaceuticals for $2.4 billion as the
London-listed group looks to build its presence in cutting-edge cancer
treatments.
24 minutes ago